Mary Rybak
6Patents
3h-index
3Co-inventors
46Inventor score
Filing activity: Oct 12, 1994 → Jun 24, 2005
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US7622458B2 | Combination of ET-743 and a 5-fluorouracil pro-drug for cancer treatment | Human Necessities | 15 | Expired |
| US6362162B1 | CML Therapy | Human Necessities | 11 | Expired |
| US6923966B2 | Melanoma therapy | Human Necessities | 7 | Expired |
| US5716612A | Use of IL-4 for potentiation of chemotherapeutic agents | Emerging Cross-Sectional Technologies | 3 | Expired |
| US5770190A | Method of treatment of acute leukemia with inteleukin-10 | Human Necessities | 1 | Expired |
| US7482014B2 | Melanoma therapy | Human Necessities | 0 | Expired |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.